Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.54 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | HPGD | P15428 | 3/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | LTB4R2 | Q9NPC1 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | GLA | P06280 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.38 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1807673 | 0.89 | TSHR (0.43) | TSHRALDH1A1HPGDTP53LTB4R2 | |
| SCHEMBL1803821 | 0.87 | TSHR (0.50) | TSHRNPSR1ALDH1A1HPGDHTT | |
| SCHEMBL6691630 | 0.85 | KMT2A (0.40) | TSHRALDH1A1HPGDTP53LTB4R2 | |
| SCHEMBL16508380 | 0.84 | TSHR (0.52) | TSHRNPSR1ALDH1A1HPGDHTT | |
| SCHEMBL29028585 | 0.83 | TSHR (0.39) | TSHRALDH1A1HPGDLTB4R2POLB | |
| SCHEMBL30267012 | 0.83 | LTB4R2 (0.40) | TSHRNPSR1ALDH1A1LTB4R2POLB | |
| SCHEMBL30221966 | 0.83 | LTB4R2 (0.40) | TSHRNPSR1ALDH1A1LTB4R2POLB | |
| SCHEMBL29028410 | 0.83 | KMT2A (0.43) | TSHRALDH1A1TP53LTB4R2MAPT | |
| SCHEMBL24914648 | 0.82 | LTB4R2 (0.39) | TSHRALDH1A1LTB4R2MAPTAKR1C3 | |
| SCHEMBL21693659 | 0.81 | HDAC1 (0.40) | TSHRLTB4R2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4610251-A1 | HEPTAFLUOROISOPROPYL-CONTAINING BISAMIDE COMPOUND AND INTERMEDIATE COMPOUND THEREOF, AND PREPARATION METHODS THEREFOR AND USE THEREOF | Zhejiang Udragon Pesticides And Chemicals Co., Ltd. (CN) | 2025-09-03 | — | — | EP | disclosed |
| CN-115974717-B | Bisamide compound containing sevoflurane isopropyl and intermediate compound thereof, preparation method and application thereof | 浙江宇龙药业有限公司 | 2025-03-14 | — | — | CN | disclosed |
| CN-113321595-B | Meta-diamide compound and application thereof | 南通泰禾化工股份有限公司 | 2023-12-22 | — | — | CN | disclosed |
| CN-115974717-A | Heptafluoroisopropyl-containing bisamide compound and intermediate compound thereof, and preparation method and application thereof | 浙江宇龙药业有限公司 | 2023-04-18 | — | — | CN | disclosed |
| CN-113321595-A | Metadiamide compound and application thereof | 南通泰禾化工股份有限公司 | 2021-08-31 | — | — | CN | disclosed |
| EP-2322502-B1 | METHOD FOR PRODUCING AMIDE DERIVATIVE | MITSUI CHEMICALS AGRO INC (JP) | 2019-09-18 | — | — | EP | disclosed |
| EP-2322502-B1 | METHOD FOR PRODUCING AMIDE DERIVATIVE | MITSUI CHEMICALS AGRO INC (JP) | 2019-09-18 | — | — | EP | disclosed |
| US-9890110-B2 | Method for producing amide derivative | MITSUI CHEMICALS AGRO, INC. (JP) | 2018-02-13 | — | — | US | disclosed |
| US-20160297750-A1 | METHOD FOR PRODUCING AMIDE DERIVATIVE | MITSUI CHEMICALS CROP & LIFE SOLUTIONS, INC. (JP) | 2016-10-13 | — | — | US | disclosed |
| US-9394240-B2 | Method for producing amide derivative | MITSUI CHEMICALS AGRO, INC. (JP) | 2016-07-19 | — | — | US | disclosed |
| US-8853440-B2 | Method for producing amide derivative | MITSUI CHEMICALS AGRO, INC. (JP) | 2014-10-07 | — | — | US | disclosed |
| US-8853440-B2 | Method for producing amide derivative | MITSUI CHEMICALS AGRO, INC. (JP) | 2014-10-07 | — | — | US | disclosed |
| US-20140296560-A1 | METHOD FOR PRODUCING AMIDE DERIVATIVE | MITSUI CHEMICALS CROP & LIFE SOLUTIONS, INC. (JP) | 2014-10-02 | — | — | US | disclosed |
| US-20140296560-A1 | METHOD FOR PRODUCING AMIDE DERIVATIVE | MITSUI CHEMICALS CROP & LIFE SOLUTIONS, INC. (JP) | 2014-10-02 | — | — | US | disclosed |
| US-20140296560-A1 | METHOD FOR PRODUCING AMIDE DERIVATIVE | MITSUI CHEMICALS CROP & LIFE SOLUTIONS, INC. (JP) | 2014-10-02 | — | — | US | disclosed |
| US-20110137068-A1 | METHOD FOR PRODUCING AMIDE DERIVATIVE | MITSUI CHEMICALS AGRO, INC. (JP) | 2011-06-09 | — | — | US | disclosed |
| US-20110137068-A1 | METHOD FOR PRODUCING AMIDE DERIVATIVE | MITSUI CHEMICALS AGRO, INC. (JP) | 2011-06-09 | — | — | US | disclosed |
| US-20110137068-A1 | METHOD FOR PRODUCING AMIDE DERIVATIVE | MITSUI CHEMICALS AGRO, INC. (JP) | 2011-06-09 | — | — | US | disclosed |
| EP-2322502-A1 | METHOD FOR PRODUCING AMIDE DERIVATIVE | Mitsui Chemicals Agro, Inc. (JP) | 2011-05-18 | — | — | EP | disclosed |
| EP-2322502-A1 | METHOD FOR PRODUCING AMIDE DERIVATIVE | Mitsui Chemicals Agro, Inc. (JP) | 2011-05-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140296560-A1 | METHOD FOR PRODUCING AMIDE DERIVATIVE | AFF4, AFF1, AFF2 | TSHR 56/4885NPSR1 1608/4885ALDH1A1 2424/4885 |
| US-20160297750-A1 | METHOD FOR PRODUCING AMIDE DERIVATIVE | AFF4, AFF1, AFF2 | TSHR 56/4885NPSR1 1608/4885ALDH1A1 2424/4885 |
| US-20110137068-A1 | METHOD FOR PRODUCING AMIDE DERIVATIVE | AFF4, AFF1, AFF2 | TSHR 56/4885NPSR1 1608/4885ALDH1A1 2424/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.